Scott Schliebner | Vice President, Scientific Affairs, Rare Diseases
PRA Health Sciences

Scott Schliebner, Vice President, Scientific Affairs, Rare Diseases, PRA Health Sciences

Appearances:



World Orphan Drug Congress USA 2019 - Day 1 @ 14:30

ROUNDTABLE 5: Patient-focused research – new approaches to bring clinical trials directly to patients and change the patient-centric trial paradigm in rare diseases

World Orphan Drug Congress USA 2019 - Day 2 @ 14:30

ROUNDTABLE 1: Gene therapy development – challenges, Issues, and solutions from the new frontier of rare disease therapies

last published: 14/Mar/19 17:55 GMT

back to speakers